A detailed history of Jcic Asset Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Jcic Asset Management Inc. holds 131 shares of ABBV stock, worth $25,640. This represents 0.01% of its overall portfolio holdings.

Number of Shares
131
Previous 131 -0.0%
Holding current value
$25,640
Previous $23,000 4.35%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 17, 2020

SELL
$64.5 - $97.79 $3,870 - $5,867
-60 Reduced 31.41%
131 $10,000
Q2 2018

Aug 08, 2018

BUY
$89.78 - $106.23 $11,761 - $13,916
131 Added 218.33%
191 $18,000
Q1 2018

Apr 09, 2018

BUY
$92.01 - $123.21 $5,520 - $7,392
60 New
60 $6,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $346B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jcic Asset Management Inc. Portfolio

Follow Jcic Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jcic Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jcic Asset Management Inc. with notifications on news.